Provide financing, M&A, business development, strategy, valuation, and restructuring advice to growth-stage corporate and private equity clients through this consultancy.

Achieved multiple milestones for SELLAS, including the completion of the company's reverse merger and the closing of a financing. Managed financial operations of this Nasdaq-listed biotech company.

Led due diligence on 4 successfully closed private equity investments with $343 million in invested capital. Sourced various acquisition and private equity investment opportunities. Build financial projections models with valuation and investment return analyses. Developed investment committee memoranda, presented investment thesis and secured approval to make investments. Monitored investments as a board observer and assisted with business development efforts.

Managed a team of three professionals in originating, executing and managing principal debt investments in, and providing opportunistic advisory services to, Russian companies in the consumer, mineral resources and technology sectors. Led a distressed takeover of a 17-door grocery store chain in central Russia. Negotiated terms of the debt-for-equity swap. Developed series of reorganization recommendations and worked with the store management on their implementation.

Served as an investment analyst reporting directly to the CEO of this family office. Evaluated investment opportunities and helped managing a portfolio of industrial and technology firms. Led business development and capital raising activities across the entire portfolio. Analyzed a $55M acquisition of a lead-acid battery manufacturer for the telecom industry. Performed valuation analysis. Delivered a recommended bid range to the Board, which approved the transaction.

Supported senior bankers in origination, structuring and execution of 46 private direct, PIPEs/RDs placement and advisory engagements valued over $1.3 billion in the health care, technology, aerospace/defense, consumer, media and communications industries. Notable deals: $25M equity private placement for Hollis-Eden Pharmaceuticals, $32M equity private placement for Solexa; €30M placement for elbion AG; $72M placement for AuthentiDate; $15M placement for Aurora Flight Sciences.